
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
05/15/2025 | Q1 | -- | $187.6M | -- | -- | -- |
02/06/2025 | Q4 | -- | $176.7M | -$0.10 | -- | -- |
11/07/2024 | Q3 | -- | $170.5M | $0.02 | -- | -- |
08/15/2024 | Q2 | -- | $136.9M | $0.04 | -- | -- |
05/08/2024 | Q1 | -- | $182.6M | $0.02 | -- | -- |
02/08/2024 | Q4 | -- | $199.3M | $0.01 | -- | -- |
11/09/2023 | Q3 | -- | -- | -$0.06 | -- | -- |
08/17/2023 | Q2 | -- | -- | -$0.02 | -- | -- |
05/11/2023 | Q1 | -- | -- | $0.09 | -- | -- |
02/09/2023 | Q4 | -- | -- | $0.04 | -- | -- |
11/03/2022 | Q3 | -- | -- | $0.13 | -- | -- |
08/11/2022 | Q2 | -- | -- | $0.07 | -- | -- |
05/12/2022 | Q1 | -- | -- | $0.14 | -- | -- |
02/10/2022 | Q4 | -- | -- | $0.07 | -- | -- |
11/04/2021 | Q3 | -- | -- | $0.03 | -- | -- |
07/29/2021 | Q2 | -- | -- | $0.06 | -- | -- |
05/06/2021 | Q1 | -- | -- | $0.05 | -- | -- |
02/11/2021 | Q4 | -- | -- | -$0.06 | -- | -- |
10/29/2020 | Q3 | -- | -- | -$0.13 | -- | -- |
07/30/2020 | Q2 | -- | -- | -$0.07 | -- | -- |
05/07/2020 | Q1 | -- | -- | -$0.04 | -- | -- |
02/06/2020 | Q4 | -- | -- | $0.05 | -- | -- |
10/31/2019 | Q3 | -- | -- | -$0.09 | -- | -- |
07/31/2019 | Q2 | -- | -- | $0.06 | -- | -- |
05/08/2019 | Q1 | -- | -- | $0.05 | -- | -- |
02/07/2019 | Q4 | -- | -- | $0.22 | -- | -- |
09/30/2018 | Q3 | -- | -- | $0.06 | -- | -- |
06/30/2018 | Q2 | -- | -- | $0.04 | -- | -- |
03/31/2018 | Q1 | -- | -- | $0.02 | -- | -- |
12/31/2017 | Q4 | -- | -- | $0.04 | -- | -- |
09/30/2017 | Q3 | -- | -- | $0.43 | -- | -- |
06/30/2017 | Q2 | -- | -- | -$0.01 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.01 | -- | -- |
12/31/2016 | Q4 | -- | -- | -$0.03 | -- | -- |
09/30/2016 | Q3 | -- | -- | -$0.00 | -- | -- |
06/30/2016 | Q2 | -- | -- | $0.00 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$0.00 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.08 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$0.01 | -- | -- |
DNO ASA reported $187.6M worth of top line sales in its most recent quarter.
DNO ASA announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
DNO ASA reported $66.5M that represents $0.07 per share over the last quarter.
DNO ASA's earnings are forecast to grow from -$0.03 per share to -- per share next year representing an increase of --.
DNO ASA's next earnings date is August 21, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.